PTEN and cancer: To answer these questions, we genetically knock-in two cancer-associated PTEN point mutations into the endogenous Pten gene in embryonic stem cells (mES): the C124S mutation, which results in a phosphatase-dead phenotype, and the G129E mutation, which results in a lipid phosphatase-dead and protein phosphatase-active phenotype.